Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Ruxolitinib in Patients With Myelofibrosis

NCT05762874 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05762874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05762874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Ruxolitinib in Patients With Myelofibrosis
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2023
Completion date
June 30, 2025
Enrollment
51 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myelofibrosis